SCHEMBL25250155

SCHEMBL25250155

CC(C)(C)OC(=O)N1CCC(c2ccc3c4c(Cl)ncnc4n(C(=O)O)c3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 1/20 0.43
▸ TLR8 Q9NR97 1/20 0.43
▸ TLR7 Q9NYK1 1/20 0.43
▸ DDB1 Q16531 1/20 0.41
▸ CRBN Q96SW2 1/20 0.41
▸ P2RY14 Q15391 1/20 0.41
▸ NAMPT P43490 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ HPGDS O60760 1/20 0.40
▸ CNR1 P21554 2/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25260977 0.95 PDE4B (0.46) TLR9TLR8TLR7MEN1KMT2A
SCHEMBL30484134 0.95 TLR9 (0.44) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25296825 0.93 TLR9 (0.45) TLR9TLR8TLR7DDB1CRBN
SCHEMBL30484120 0.89 PDE4B (0.47) TLR9TLR8TLR7PIK3CDHPGDS
SCHEMBL25831135 0.89 PDE4B (0.47) TLR9TLR8TLR7PIK3CDHPGDS
SCHEMBL25830816 0.87 TLR9 (0.46) TLR9TLR8TLR7DDB1CRBN
SCHEMBL31017625 0.87 TLR9 (0.46) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25427387 0.86 DDB1 (0.41) DDB1CRBNMEN1KMT2AUSP2
SCHEMBL25831704 0.80 DDB1 (0.42) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25427872 0.78 BTK (0.35) NAMPTPIK3CDCNR1EGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125907-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2023-07-06 — — WO disclosed
Send feedback